不可逆电穿孔联合 CAR-NK 细胞治疗肝细胞癌的协同免疫治疗效果发表
Electrical ablation boosts CAR-NK cell therapy against liver cancer, offering new strategy for refractory solid tumors
成均馆大学研究团队在 Signal Transduction and Targeted Therapy 发表研究,将不可逆电穿孔(IRE)与靶向 GPC3 的 CAR-NK 细胞联用治疗肝细胞癌。IRE 通过释放损伤相关分子模式和趋化因子重塑免疫抑制微环境,增强 NK 细胞募集与杀伤,联合治疗在多种临床前模型中显示出优于单一疗法的肿瘤控制和生存期延长。
A research team has developed a combination immunotherapy that uses an electrical ablation technique to enhance the efficacy of immune cell therapy against liver cancer.
The team, led by Professor Wooram Park of the Department of Integrative Biotechnology at Sungkyunkwan University (SKKU), used irreversible electroporation (IRE) to reshape the immunosuppressive tumor microenvironment in liver cancer and enhance the anticancer activity of chimeric antigen receptor natural killer (CAR-NK) cells.
The study is published in the journal Signal Transduction and Targeted Therapy.
The team also identified the key molecular mechanisms underlying this therapeutic effect. Joo Dong Park and Ha Eun Shin, researchers in Park's group, served as co-first authors of the study.
Conventional immune cell–based cancer therapies often suffer from limited infiltration of therapeutic cells into tumors and reduced efficacy due to the immunosuppressive tumor microenvironment. Hepatocellular carcinoma, in particular, has a highly immunosuppressive environment, making it difficult to achieve sufficient therapeutic effects with CAR-NK cell therapy alone.
To overcome this limitation, the research team developed an approach using IRE, a clinically approved nonthermal ablation technique, to remodel the tumor microenvironment.
IRE destroys tumor cells using high-voltage pulsed electric fields. This process induces the release of damage-associated molecular patterns (DAMPs) and chemokines—chemical signaling proteins that attract immune cells—thereby transforming the tumor microenvironment into one that is more favorable for NK cell activity.
The researchers found that chemokine levels within tumors increased significantly after IRE treatment, leading to the early recruitment of NK cells. They also identified a mechanism in which increased reactive oxygen species (ROS) generated by IRE made residual tumor cells markedly more susceptible to NK cell–mediated killing.
The team then combined IRE with glypican-3 (GPC3)-targeted CAR-NK cells generated using lipid nanoparticle (LNP)-based gene delivery technology. The combination produced substantially stronger tumor control than either treatment alone.
In vitro, IRE-treated liver cancer cells were rapidly eliminated by CAR-NK cells. Across multiple preclinical models, the combination of IRE and CAR-NK cell therapy also demonstrated superior tumor suppression and prolonged survival.
Wooram Park said, "This study is significant because it combines IRE, an LNP platform and CAR-NK cells—all technologies that have already entered or are approaching clinical application—to improve the local tumor environment and deliver precision cellular immunotherapy. We expect this approach to develop into a combination therapy that can be translated more rapidly into clinical practice."
More information
Joo Dong Park et al, Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma, Signal Transduction and Targeted Therapy (2026). DOI: 10.1038/s41392-026-02627-2
Clinical categories
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Electrical ablation boosts CAR-NK cell therapy against liver cancer, offering new strategy for refractory solid tumors (2026, October 8) retrieved 8 October 2026 from https://medicalxpress.com/news/2026-10-electrical-ablation-boosts-car-nk.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com